Persistent Sox9 expression in hypertrophic chondrocytes suppresses transdifferentiation into osteoblasts

Area of Science:

• Molecular Biology
• Developmental Biology
• Skeletal Biology

Background:

• Longitudinal bone growth relies on endochondral ossification, where chondrocytes create cartilage remodeled into bone by osteoblasts.
• Hypertrophic chondrocytes at the growth plate may undergo apoptosis or transdifferentiate into osteoblasts.
• The molecular control of this chondrocyte-to-osteoblast lineage switch is not well understood.

Purpose of the Study:

• To investigate the role of Sox9 downregulation in hypertrophic chondrocytes during endochondral ossification.
• To elucidate the molecular mechanisms governing chondrocyte transdifferentiation into osteoblasts.

Main Methods:

• Analysis of Sox9 expression and osteoblast-associated gene expression (Mmp13, Cola1, Ibsp) in hypertrophic chondrocytes.
• Generation and analysis of transgenic mice with sustained Sox9 expression in chondrocytic lineage cells.
• Lineage tracing experiments in transgenic mice to track chondrocyte differentiation.

Main Results:

• Physiological downregulation of Sox9 in hypertrophic chondrocytes correlates with increased expression of osteoblast genes.
• Sustained Sox9 expression in transgenic mice prevented the upregulation of osteoblast genes in hypertrophic chondrocytes.
• Lineage tracing revealed a significant reduction in chondrocyte-to-osteoblast transdifferentiation in Sox9-expressing transgenic mice.

Conclusions:

• Sox9 downregulation in hypertrophic chondrocytes is a key event that promotes osteoblast-associated gene expression.
• This Sox9 downregulation facilitates the transdifferentiation of hypertrophic chondrocytes into osteoblasts, a critical step in bone formation.